Testicular cancer before and after cisplatin: a 30-year view

被引：0
作者：
Ansell, Wendy [1 ]
Shamash, Jonathan [1 ]
机构：
[1] St Bartholomews Hosp, London EC1A 7BE, England
来源：
INTERNATIONAL JOURNAL OF UROLOGICAL NURSING | 2008年 / 2卷 / 03期
关键词：
Historical perspective; Multidisciplinary working; Survivorship; Testicular cancer; Testicular germ cell tumours; Treatment advances;
D O I：
10.1111/j.1749-771X.2008.00060.x
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Exciting changes have been made in the management of testicular germ cell cancers over the past 30 years. Today, more than 80% of men who present with metastatic disease are cured compared with about 15% in the early 1970s. This means that there are a large number of survivors and many of them have willingly provided information that can be used in shaping the management of other malignancies. The paper aims to summarize the current management of testicular germ cell cancers comparing the situation in the pre-platinum era with that today and to consider current and future developments in the management of this disease.
引用
收藏
页码：103 / 112
页数：10
相关论文
共 50 条
  • [31] PHANTOM SENSATIONS AFTER ORCHIECTOMY FOR TESTICULAR CANCER
    BOKEMEYER, C
    FRANK, B
    SCHOFFSKI, P
    POLIWODA, H
    SCHMOLL, HJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (04) : 633 - 636
  • [32] Regeneration of Spermatogenesis after Testicular Cancer Chemotherapy
    Suzuki, Kotaro
    Yumura, Yasushi
    Ogawa, Takehiko
    Saito, Kazuo
    Kinoshita, Yuzo
    Noguchi, Kazunii
    UROLOGIA INTERNATIONALIS, 2013, 91 (04) : 445 - 450
  • [33] SEMEN QUALITY AFTER TREATMENT FOR TESTICULAR CANCER
    FOSSA, SD
    AABYHOLM, T
    VESPESTAD, S
    NORMAN, N
    OUS, S
    EUROPEAN UROLOGY, 1993, 23 (01) : 172 - 176
  • [34] Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy
    Brydoy, Marianne
    Fossa, Sophie D.
    Klepp, Olbjorn
    Bremnes, Roy M.
    Wist, Erik A.
    Wentzel-Larsen, Tore
    Dahl, Olav
    EUROPEAN UROLOGY, 2010, 58 (01) : 134 - 140
  • [35] Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer
    Stensvold, E
    Aass, N
    Gladhaug, I
    Stenwig, AE
    Claussen, OP
    Fosså, SD
    EJSO, 2004, 30 (03): : 352 - 355
  • [36] TESTICULAR TURNER AFTER CISPLATIN-BASED CHEMOTHERAPY FOR GERM-CELL MALIGNANCY
    GERL, A
    CLEMM, C
    KOHL, P
    WILMANNS, W
    EUROPEAN UROLOGY, 1994, 25 (03) : 216 - 219
  • [37] Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
    Bokemeyer, C
    Beyer, J
    Metzner, B
    Ruther, U
    Harstrick, A
    Weissbach, L
    Kohrmann, U
    Verbeek, W
    Schmoll, HJ
    ANNALS OF ONCOLOGY, 1996, 7 (01) : 31 - 34
  • [38] Comprehensive Characterization of the Vascular Effects of Cisplatin-Based Chemotherapy in Patients With Testicular Cancer
    Cameron, Alan C.
    McMahon, Kelly
    Hall, Mark
    Neves, Karla B.
    Rios, Francisco J.
    Montezano, Augusto C.
    Welsh, Paul
    Waterston, Ashita
    White, Jeff
    Mark, Patrick B.
    Touyz, Rhian M.
    Lang, Ninian N.
    JACC: CARDIOONCOLOGY, 2020, 2 (03): : 443 - 455
  • [39] Cisplatin - DNA adducts and protein-bound platinum in blood of testicular cancer patients
    Boffetta, P
    Fichtinger-Schepman, AMJ
    Weiderpass, E
    van Dijk-Knijnenburg, HCM
    Stoter, G
    van Oosterom, AT
    Keizer, HJ
    Fossa, SD
    Kaldor, J
    Roy, P
    ANTI-CANCER DRUGS, 1998, 9 (02) : 125 - 129
  • [40] The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study
    Rossini, Elisa
    Tamburello, Mariangela
    Abate, Andrea
    Zini, Silvia
    Ribaudo, Giovanni
    Gianoncelli, Alessandra
    Calza, Stefano
    Valcamonico, Francesca
    Suardi, Nazareno R.
    Mirabella, Giuseppe
    Berruti, Alfredo
    Sigala, Sandra
    CELLS, 2024, 13 (05)
12345